The mean baseline body weight was 88.6 kg, 89 kg and 88.1 kg in the placebo, semaglutide tablets 7 mg, and semaglutide tablets 14 mg arms, respectively
RELATED: Ozempic for weight loss Key differences between compounded semaglutide and FDA-approved brands Wegovy and Ozempic contain the same active ingredient, semaglutide, a GLP-1 receptor agonist that is FDA approved for weight management and Type 2 diabetes, respectively
Incorrect dosing may result in inadequate therapeutic effect or increased adverse events including nausea, vomiting, and diarrhea
(00:56:45) Resveratrol, NAD, NMN, NR
The Ozempic SmPC includes warnings about the risk of dehydration and potential acute kidney injury with significant gastrointestinal losses